Vigil Neuroscience (NASDAQ:VIGL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vigil Neuroscience (VIGL) operate in?

Vigil Neuroscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vigil Neuroscience Stock (NASDAQ: VIGL) stock price, news, charts, stock research, profile.

Open	$1.77
Close	$1.70
Volume / Avg.	794.97K / 171.08K
Day Range	$1.65 - $1.89
52 Wk Range	1.60 - 6.06
Market Cap	$69.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	3.18%
Days to Cover	2.76

Recent News

Small Neurodegenerative Disease-Focused Vigil Neuroscience Says Alzheimer's Candidate Shows Significant Impact On Disease Bimarker

Vigil Neuroscience reports promising interim results from its Phase 1 trial of VG-3927, showing a strong safety, tolerability, and pharmacokinetic profile in healthy volunteers. The data support continued development of VG-3927 as a potential daily oral therapy for Alzheimer's disease.

Vandana Singh

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.

Zacks

Why Is Rare Neurological Disease Focused Vigil Neuroscience Stock Trading Lower Today?

Vigil Neuroscience Inc (NASDAQ: VIGL) shares are down after the company released interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a neurological condition characterized by changes to&nb

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.77
Close	$1.70
Volume / Avg.	794.97K / 171.08K
Day Range	$1.65 - $1.89
52 Wk Range	1.60 - 6.06
Market Cap	$69.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	3.18%
Days to Cover	2.76

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vigil Neuroscience (VIGL) stock?

You can purchase shares of Vigil Neuroscience (NASDAQ:VIGL) through any online brokerage.

View our list of the best stock brokerages

Who are Vigil Neuroscience (VIGL) competitors?

Other companies in Vigil Neuroscience’s space includes: Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Inovio Pharmaceuticals (NASDAQ:INO) and Vistagen Therapeutics (NASDAQ:VTGN).

What is the forecast, or price target, for Vigil Neuroscience (VIGL) stock?

Vigil Neuroscience has a consensus price target of $17.22.

What is the current price for Vigil Neuroscience (VIGL)?

The stock price for Vigil Neuroscience (NASDAQ: VIGL) is $1.7 last updated December 20, 2024 at 6:53 PM EST.

Does Vigil Neuroscience (VIGL) pay a dividend?

There are no upcoming dividends for Vigil Neuroscience.

When is Vigil Neuroscience (NASDAQ:VIGL) reporting earnings?

Vigil Neuroscience’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Vigil Neuroscience (VIGL) going to split?

There is no upcoming split for Vigil Neuroscience.

What sector and industry does Vigil Neuroscience (VIGL) operate in?

Vigil Neuroscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vigil Neuroscience

Vigil Neuroscience (VIGL) Forecast